Board of Directors
The Lymphoma Research Foundation’s Board of Directors is comprised of business leaders, medical professionals and lymphoma survivors and Foundation supporters from across the United States who utilize their skills and expertise to further the LRF mission.
STEVEN EICHBERG
Chair, Board of Directors
Plymouth, MA
Steven Eichberg is Chair of the Lymphoma Research Foundation’s Board of Directors. Diagnosed in 2012 with follicular lymphoma, Steven has benefited by the years of research being done by LRF’s scientific community to provide new and innovative agents for treatment and today is a Lymphoma Thriver. He has a background in marketing and operations, where he previously led both for-profit and non-profit organizations on outreach strategy. A long-time supporter of LRF, Eichberg is also a photography, golf, and travel enthusiast.
JEFF BLOCK
Vice Chair and Treasurer
San Francisco, CA
KIM METCALF
Vice Chair
Landenberg, PA
LEIGH OLSON
Secretary
Miami Beach, FL
MICHAEL AKINYELE
Upper Marlboro, MD
MICHAEL FROY
Chicago, IL
HARRIET GREENBERG
New York, NY
JOHN P. LEONARD, MD
Past Chair, Scientific Advisory Board
New York, NY
BOB MCAULEY
Charlottesville, VA
JOHN A. NELSON
Westport, CT
SCOTT PANSKY
Los Angeles, CA
DIANE PARKS
Carbondale, CO
JOEL POLLICK
Brooklyn, NY
STEVEN J. PRINCE
Past Chair
Purchase, NY
KEVIN SHEA
SONALI M. SMITH, MD, FASCO
Chair, Scientific Advisory Board
Chicago, IL
MICHAEL WERNER
Immediate Past Chair
Chicago, IL
Directors Emeritus
JOSEPH R. BERTINO, MD
(In Memoriam)
Founding Chair, Scientific Advisory Board
New Brunswick, NJ
MORTON COLEMAN, MD
New York, NY
ERROL M. COOK
(In Memoriam)
Past Chair
Boca Raton, FL
JERRY FREUNDLICH
Founder and Past Chair
New York, NY
ROBERT WERNER
Aventura, FL
TOM GOLDSTONE
New York, NY
For additional information regarding volunteer leadership opportunities at the Lymphoma Research Foundation, please email your request, including your name and contact information, to: leadership@lymphoma.org.
Download the full list of LRF Board of Directors
“I have realized that my true passion involves preclinical and clinical development of novel strategies to treat lymphoma patients.”
The Ohio State University
